Predominant deposition of amyloid-β42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene

American Journal of Pathology

Volumn 148, Issue 4, 1996, Pages 1257-1266

  Mann, D M A ^a   Iwatsubo, T ^b   Ihara, Y ^b   Cairns, N J ^c   Lantos, P L ^c   Bogdanovic, N ^d   Lannfelt, L ^d   Winblad, B ^d   Maat Schieman, M L C ^e   Rossor, M N ^f  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF TOKYO   (Japan)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f National Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MONOCLONAL ANTIBODY;

ADULT; ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SENILE PLAQUE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; NEUROFIBRILLARY TANGLES;

EID: 0029869667     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Mann DMA: Alzheimer's disease: progress in pathological and aetiological aspects. Rev Clin Gerontol 1994, 4:43-60
2. Selkoe DJ Normal and abnormal biology of the β-amyloid precursor protein. Annu Rev Neurosci 1994, 17: 489-517
3. Lannfelt L, Bogdanovic N, Appelgren H, Axelman K, Lilius L, Hansson Q, Schenk D, Hardy J, Winblad B: Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family. Neurosci Lett 1994, 168: 254-256
4. Naruse S, Igarashi S, Aoki K, Kaneko K, Iihara K, Miyatake T, Kobayashi H, Inuzuka T, Shimizu T, Kojima T, Tsuji S. Missense mutation val-→ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet 1991, 337:978-979
5. Yoshizawa T, Komatsuzaki Y, Iwamoto H, Mizusawa H, Kanazawa I: Screening of the mis-sense mutation producing the 717 val→ile substitution in the amyloid precursor protein in Japanese familial and sporadic Alzheimer's disease. J Neural Sci 1993, 117:12-15
6. Mullan M, Tsuji S, Miki T, Katsuya T, Naruse S, Kaneko K, Shimizu T, Kojima K, Nakano I, Ogihara T, Miyatake T, Ovenstone I, Crawford F, Goate A, Hardy J, Roques P, Roberts G, Luthert P, Lantos P, Clark C, Gaskell P, Cram B, Roses AD: Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 val-ile mutation in the amyloid precursor protein gene. Neurobiol Aging 1993, 14:407-419
7. Lantos PL, Ovenstone IMK, Johnson J, Clelland CA, Roques P, Rossor MN: Lewy bodies in the brain of two members of a family with the 717 (val to ile) mutation of the amyloid precursor protein gene. Neurosci Lett 1994, 172 77-79
8. Lantos PL, Luthert PJ, Hanger D, Anderton BH, Mullan M, Rossor M Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology Neurosci Lett 1992, 137:221-224
9. Cairns NJ, Chadwick A, Lantos PL, Levy R, Rossor MN βA4 protein deposition in familial Alzheimer's disease with the mutation in codon 717 of the β/A4 amyloid precursor protein gene and sporadic Alzheimer's disease. Neurosci Lett 1993, 149:137-140
10. Mann DMA, Jones D, Snowden JS, Neary D, Hardy J Pathological changes in the brain of a patient with familial Aizheimer's disease having a missense mutation at codon 717 in the amyloid precursor protein gene. Neurosci Lett 1992, 137:225-228
11. Hanger DP, Mann DMA, Neary D, Anderton BH. Tau pathology in a case of familial Aizheimer's disease with a valine to glycine mutation at position 717 in the amyloid precursor protein Neurosci Lett 1992, 145:178-180
12. Ghetti B, Murrell J, Benson MD, Farlow MR: Spectrum of amyloid β-protein immunoreactivity in hereditary Alzheimer's disease with a guanine to thymine missense change at position 1924 of the APP gene. Brain Res 1992, 571:133-139
13. Hendriks L, Van Duijn CM, Cras P, Cruts M, Van Hul W, Van Harskamp F, Warren A, McInnis MG, Antonarakis SE, Martin J-J, Hofman A, Van Broeckhoven C: Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene Nat Genet 1992, 1:218-221
14. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, Van Duinen SG, Bots GTAM, Luyendijk W, Frangione B Mutation of the Aizheimer's disease amyloid gene in hereditary cerebral haemorrhage, Dutch type. Science 1990, 248 1124-1126
15. Van Duinen SG, Castano EM, Prelli F, Bots GTAM, Luyendijk W, Frangione B: Hereditary cerebral hemorrhage with amyloidosis in patients of the Dutch origin is related to Alzheimer disease Proc Natl Acad Sci USA 1987, 84:5991-5994
16. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski I, Lieberburg I, Koo EH, Schenk D, Teplow DB, Selkoe DJ: Amyloid β-peptide is produced by cultured cells during normal metabolism Nature 1992, 359:322-325
17. Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis DL, Bryant K, Fritz LC, Galasko D, Thal LJ, Lieberburg I, Schenk D. Secretion of β-amyloid precursor protein cleaved at the aminoterminus of the β-amyloid peptide Nature 1992, 361:260-263
18. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Schaffer LM, Cai X-D, McKay DM, Tintner R, Frangione B, Younkin SG. Production of the Alzheimer amyloid β protein by normal proteolytic processing Science 1992, 258:126-129
19. Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, Schenk DB Characterization of β-amyloid peptide from human cerebrospinal fluid. J Neurochem 1993, 61:1965-1968
20. Dovey HF, Suomesaari-Chrysler S, Lieberburg I, Sinha S, Kiem P: Cells with a familial Aizheimer's disease mutation produce authentic β-peptide NeuroReport 1993, 4:1039-1042
21. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K: Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985, 82:4245-4249
22. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 1993, 301:41-52
23. Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, Reardon IM, Zurcher-Neely HA, Heinrikson RL, Ball MJ, Greenberg B: Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 1993, 268:3072-3083
24. Gowing E, Roher AE, Woods AS, Cotter RJ, Chaney M, Little SP, Ball MJ Chemical characterization of Aβ17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease J Biol Chem 1994, 269: 10987-10990
25. Naslund J, Schierhorn A, Hellman U, Lannfelt L, Roses AD, Tjernberg LO, Silberring J, Gandy SE, Winblad B, Greengard P, Norstedt C, Terenius L Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci USA 1994, 91:8378-8382
26. Tamaoka A, Odaka A, Ishibashi Y, Usami M, Suharu N, Suzuki N, Nukina N, Mizusawa H, Shoji S, Kanazawa I, Mori H: APP717 mis-sense mutation affects the ratio of amyloid β protein species (Aβ1-42/43 and AB1-40) in familial Alzheimer's disease brain J Biol Chem 1994, 269:32721-32724
27. Tabaton M, Nunzi MG, Xue R, Usiak M, Autiho-Gambetti L, Gambetti P: Soluble amyloid β protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem Biophys Res Commun 1994, 200:1598-1603
28. 42(43) J Biol Chem 1995, 270 7013-7016
29. Jarrett JT, Berger EP, Lansbury PT: The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation, implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993, 32:4693-4697
30. Glenner GG, Wong CW: Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984, 120:885-890
31. Joachim CL, Duffy LK, Morris JH, Selkoe DJ: Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal ageing. Brain Res 1988, 474:100-111
32. Prelii F, Castano E, Glenner GG, Frangione B. Differences between vascular and plaque core amyloid in Alzheimer's disease J Neurochem 1988, 51:648-651
33. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, Ball MJ β-Amyloid (1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer's disease. Proc Natl Acad Sci USA 1993, 90:10836-10840
34. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y Visualization of Aβ42(43)-positive and Aβ40-positive senile plaques with end-specific Aβ-monoclonal antibodies: evidence that an initially deposited Aβ species is Aβ1-42(43). Neuron 1994, 13:45-53
35. Murphy GM, Forno LS, Higgins L, Scardina JM, Eng LF, Cordell B. Development of a monoclonal antibody specific for the COOH-terminal of β-amyloid 1-42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders. Am J Pathol 1994, 144:1082-1088
36. Mak K, Yang F, Vinters HV, Frautschy SA, Cole GM Polyclonals to β-amyloid (1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum. Brain Res 1994, 667:138-142
37. Iwatsubo T, Mann DMA, Odaka A, Suzuki N, Ihara Y: Amyloid β protein (Aβ) deposition Aβ42(43) precedes Aβ40 in Down syndrome. Ann Neurol 1995, 37:294-299
38. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ: Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 1992, 360:672-674
39. Cai X-D, Golde TE, Younkin SG: Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 1993, 259:514-516
40. Felsenstein KM, Hunihan LW, Roberts SB. Altered cleavage and secretion of a recombinant β-APP bearing the Swedish familial Alzheimer's disease mutation Nat Genet 1994, 6 251-256
41. Suzuki N, Cheung TT, Cai X-D, Odaka A, Otvos L, Eckman C, Golde TE, Younkin SG. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 1994, 264 1336-1340
42. Maat-Schieman MLC, Radder CM, Van Duinen SG, Haan J, Roos RAC. Hereditary cerebral haemorhage with amyloidosis (Dutch) a model for argyrophilic plaque formation without neurofibrillary pathology. Acta Neuropathol 1994, 88:371-378
43. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyden B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J: Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 1995, 373:523-527
44. 40 containing plaques. Acta Neuropathol 1995, 90:472-477
45. 40-positive senile plaques with microglial cells in the brains of patients with Alzheimer's disease and in non-demented aged individuals. Neurodegeneration 1996 (in press)
46. Hardy J, Houlden H, Collinge J, Kennedy A, Newman S, Rossor M, Lannfelt L, Lilius L, Winblad B, Crook R, Duff K: Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993, 342:737-738
47. Johnston A, Cowburn RF, Norgren S, Wiehager B, Venizelos N, Winblad B, Vigo-Pelfrey C, Schenk D, Lannfelt L, O'Neill C: Increased β-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation. FEBS Lett 1994, 354:274-278
48. 42(43). Ann Neurol 1996 (in press).
49. 40 with cored plaques. Am J Pathol 1996, 148:259-265